論文

国際誌
2021年5月21日

Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells.

iScience
  • Emi Sano
  • ,
  • Sayaka Deguchi
  • ,
  • Ayaka Sakamoto
  • ,
  • Natsumi Mimura
  • ,
  • Ai Hirabayashi
  • ,
  • Yukiko Muramoto
  • ,
  • Takeshi Noda
  • ,
  • Takuya Yamamoto
  • ,
  • Kazuo Takayama

24
5
開始ページ
102428
終了ページ
102428
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.isci.2021.102428

Genetic differences are a primary reason for differences in the susceptibility and severity of COVID-19. As induced pluripotent stem (iPS) cells maintain the genetic information of the donor, they can be used to model individual differences in SARS-CoV-2 infection in vitro. We found that human iPS cells expressing the SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) (ACE2-iPS cells) can be infected w SARS-CoV-2. In infected ACE2-iPS cells, the expression of SARS-CoV-2 nucleocapsid protein, budding of viral particles, and production of progeny virus, double membrane spherules, and double-membrane vesicles were confirmed. We performed SARS-CoV-2 infection experiments on ACE2-iPS/ embryonic stem (ES) cells from eight individuals. Male iPS/ES cells were more capable of producing the virus compared with female iPS/ES cells. These findings suggest that ACE2-iPS cells can not only reproduce individual differences in SARS-CoV-2 infection in vitro but also are a useful resource to clarify the causes of individual differences in COVID-19 due to genetic differences.

リンク情報
DOI
https://doi.org/10.1016/j.isci.2021.102428
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33880436
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051014
ID情報
  • DOI : 10.1016/j.isci.2021.102428
  • PubMed ID : 33880436
  • PubMed Central 記事ID : PMC8051014

エクスポート
BibTeX RIS